Big Pharma could face losses if the newly split government can reach a consensus on drug prices
Share Now on:
There is already public consensus that drug prices are too high. Both Democrats and President Donald Trump have vowed to lower them. Yet, even with a new Democratic majority in the House, they may face challenges lowering pharmaceutical costs. Politically divided governments are often synonymous with gridlock, even on an issue as widely supported as drug prices. For their part, markets are signaling a belief in continued gridlock.
If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air. But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.
Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.
When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.